Abstract:Sirtuin-3 (SIRT3) is an NAD+-dependent protein deacetylase localized primarily in the mitochondria with many links to different types of human cancers. Autophagy, which is a highly conserved lysosomal degradation process in eukaryotic cells, has been recently reported to be positively regulated by SIRT3 in cancer; therefore, activating SIRT3-modulated autophagy may be a promising strategy for drug discovery. In this study, we discovered a small-molecule activator of SIRT3 compound 33c (ADTL-SA1215) with specific SIRT3 deacetylase activity by structure-guided design and high-throughput screening. Subsequently, compound 33c inhibited the proliferation and migration of human breast carcinoma MDA-MB-231 cells by SIRT3-driven autophagy/mitophagy signaling pathways in vitro and in vivo. Collectively, these results demonstrate that pharmacological activation of SIRT3 is a potential therapeutic approach of triple negative breast cancer (TNBC). More importantly, compound 33c may be a first-in-class specific small-molecule activator of SIRT3 that would be utilized for future cancer drug development.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02268.Representative crystal structures of SIRT3 in complex with cofactors, substrates, and ligands; predicted binding sites for different SIRT proteins; possible binding sites near NAD+; 100 ns molecular dynamics simulation of system 1 (SIRT3 + NAD+) and system 2 (SIRT3 + NAD+ + substrate); molecular docking of top 20 compounds with SIRT3 pocket U; binding mode of ZINC03830212 and SIRT3 in chain B; comparison of SIRT3 deacetylation activity of resveratrol, honokiol, and 33c; sequence alignment of SIRT1, SIRT2, SIRT3, and SIRT5; binding modes of 33c with SIRT1, SIRT2, SIRT3, and SIRT5; western blot analysis of the acetylation and succinylation level of cellular mitochondria extracts after 33c treatment ; binding sites on SIRT3 for different ligands compared with ZINC03830212 and 33c; effect of ZINC03830212 and 33c on MCF10A cells; HE staining of the lungs taken from TNBC xenograft mice; top 20 compounds based upon Pocket U screening; original data of co-immunoprecipitation and western blot; HPLC, MS, and NMR data (PDF)Molecular formula strings and the associated biochemical and biological data (CSV)This article has not yet been cited by other publications.

SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target

Activation and inhibition of sirtuins: From bench to bedside

SIRT1 Activation by Natural Phytochemicals: An Overview

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Context-dependent role of SIRT3 in cancer

Advances in SIRT3 involvement in regulating autophagy-related mechanisms

Roles of SIRT3 in Heart Failure: from Bench to Bedside.

Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective

Current Trends in Sirtuin Activator and Inhibitor Development

SIRT3, a New Hope in Liver Diseases from Pathogenic Mechanisms to Therapeutic Strategies

Mitochondrial sirtuin 3 and role of natural compounds: the effect of post-translational modifications on cellular metabolism

Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer

Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer

The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications

A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research

The role of SIRT3 in homeostasis and cellular health

SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status

<i>SIRT3</i> interacts with the <i>daf-16</i> homolog <i>FOXO3a</i> in the Mitochondria, as well as increases <i>FOXO3a</i> Dependent Gene expression

The role of SIRT1 in kidney diseases